Currently, there are 426.22M common shares owned by the public and among those 388.27M shares have been available to trade.
The company’s stock has a 5-day price change of 4.65% and -26.86% over the past three months. GME shares are trading 27.04% year to date (YTD), with the 12-month market performance up to 10.30% higher. It has a 12-month low price of $9.95 and touched a high of $64.83 over the same period. GME has an average intraday trading volume of 50.37 million shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by -5.22%, -11.84%, and 26.26% respectively.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Institutional ownership of Gamestop Corporation (NYSE: GME) shares accounts for 20.82% of the company’s 426.22M shares outstanding.
It has a market capitalization of $9.49B and a beta (3y monthly) value of -0.03. The stock’s trailing 12-month PE ratio is 273.25, while the earnings-per-share (ttm) stands at $0.08. Price movements for the stock have been influenced by the stock’s volatility, which stands at 3.99% over the week and 5.73% over the month.
Earnings per share for the fiscal year are expected to decrease by -266.67%, and 25.00% over the next financial year.
Looking at the support for the GME, a number of firms have released research notes about the stock. Wedbush stated their Underperform rating for the stock in a research note on June 08, 2023, with the firm’s price target at $6.50-$6.20. Ascendiant Capital Markets coverage for the Gamestop Corporation (GME) stock in a research note released on April 12, 2021 offered a Sell rating with a price target of $10. Telsey Advisory Group was of a view on March 24, 2021 that the stock is Underperform, while Wedbush gave the stock Underperform rating on March 24, 2021, issuing a price target of $16- $29. BofA Securities on their part issued Underperform rating on January 27, 2021.
